Skip to content
Screener

Roivant Sciences ROIV United States — Net operating losses

Similar metrics at other companies

SSR Mining logo
SSRMUnited States — Tax operating losses
$1.39M+0.1%
Belden logo
BDCUnited  States — Net Operating Loss Carryforwards
$35.83M-8.7%
Hayward Holdings logo
HAYWUnited States — Net operating loss carryforward
$12.6M0.0%
Immunovant, Inc. logo
IMVTUnited States — Net operating loss carry forwards
$195.2M+301%
GigaCloud Technology logo
GCTUnited States — Operating loss carryforwards
$4.5M0.0%
Citizens logo
CIAUnited States — Operating Loss Carryforwards
$7.1M+12.7%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25.37B+219%
Enterprise value$25.4B+219%
P/S3,368×+3,026×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.

The source filing: Roivant Sciences’s 10-K, filed May 20, 2026.

Filed
May 20, 2026, 7:17 AM EDT
Fiscal year
FY2025
Accession
0001635088-26-000061

The Company has net operating losses in Switzerland, the U.S. and the U.K. in the amount of $1,512.9 million, $890.7 million and $613.4 million, respectively. The Switzerland net operating losses will expire in varying amounts between March 31, 2027 and March 31, 2032. The U.S. net operating losses can be carried forward indefinitely with utilization limited to 80% of future taxable income for tax years beginning on or after January 1, 2021, while the U.K. and other net operating losses can be carried forward indefinitely as well, with an annual limitation on utilization. The Company has $66.0 million of federal research tax credit carryforwards in the U.S., which will expire in varying amounts between March 31, 2039 and March 31, 2046. Additionally, credits of $10.8 million are related to various states and Canada.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Roivant Sciences's united states — net operating losses?
Roivant Sciences (ROIV) reported united states — net operating losses of $890.7M in Q1 2026.
How has Roivant Sciences's united states — net operating losses changed year-over-year?
Roivant Sciences's united states — net operating losses increased by 298.9% year-over-year, from $223.3M to $890.7M.
What does united states — net operating losses mean?
This represents the accumulated tax losses incurred by the U.S. operations that can be carried forward to offset future taxable income. These losses serve as a significant tax asset, potentially reducing future tax liabilities and preserving cash. Investors track this to evaluate the company's ability to shield future earnings from taxation.

Ask your AI about Roivant Sciences's united states — net operating losses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude